ArticleBMC rheumatology2025

Detailed assessment of axial and peripheral entheses and joints in axial spondyloarthritis and psoriatic arthritis patients treated with ixekizumab (DAPHNE): design of a 2-year phase IV trial applying whole-body MRI, MRI-based synthetic CT, and CT.

Simone Tromborg Willesen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.